 |
|
| Venture Capital Bio Life Sciences (page 3 of 20) |
|
-Bay City-
Offices: San Francisco, California
Bay City Capital was established in 1997 as an equal partnership between
The Craves Group and certain Pritzker family business interests for the
purpose of managing investment funds in the life sciences industry and related
activities. Since that date, they’ve managed four life sciences investment
funds representing $476 million in committed capital, invested in 50 companies.
Offices: Zurich, Switzerland
BB Biotech AG was founded in November 1993 as an investment company and
invests in biotech companies globally. BB Biotech has meanwhile become one
of the largest pure play biotech investors. BB Biotech shares are listed
on the Swiss Stock Market, in the "TecDax" in Germany and the Italian "Star-Segment".
BB Biotech offers its shareholders the opportunity to participate in biotech
growth with above-average appreciation potential.
Offices: New York, New York
Bear Stearns Health Innoventures seeks to invest in innovative early to
mid-stage companies that have the potential to deliver better medicines
or deliver medicine better. The Fund focuses on companies with platform
technologies that will generate productivity improvements across the health
care value chain: discovery, development and delivery. Health Innoventures
will leverage its access to the global resources of a full service investment
bank.
Offices: Chicago, Illinois
Beeken Petty O'Keefe is a private equity management firm founded in 1996
to invest in middle-market buy-out transactions, recapitalizations, and
growth platforms in the health care industry. They pride themselves in maintaining
a collaborative relationship among all of their partners and portfolio company
executives, ensuring all portfolio companies access to the full range of
the firm's experience and intellectual resources. 
Print
(page 4)
Resources
to
top